China Biologic Products to Report First Quarter 2013 Financial Results
BEIJING, May 2, 2013
BEIJING, May 2, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc.
(NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated
plasma-based biopharmaceutical company in China, today announced that the
Company plans to release first quarter 2013 financial results on Wednesday,
May 8, 2013 after the market closes.
The Company's management will hold a conference call at 7:30 a.m. ET on
Thursday, May 9, 2013 to discuss first quarter 2013 results. Listeners may
access the call by dialing 1-480-629-9857. A live and archived webcast of the
conference call will be available at http://public.viavid.com, with event ID:
104670. A replay of the call will be available through May 23, 2013 by dialing
1-858-384-5517, access code: 4618459.
About China Biologic Products, Inc.
China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated
plasma-based biopharmaceutical company in China. The Company's products are
used as critical therapies during medical emergencies and for the prevention
and treatment of life-threatening diseases and immune-deficiency related
diseases. China Biologic is headquartered in Beijing and manufactures over 20
plasma-based products through its indirect majority-owned subsidiaries,
Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic
Technologies Co., Ltd. The Company also has an equity investment in Xi'an
Huitian Blood Products Co., Ltd. The Company sells its products to hospitals
and other healthcare facilities in China. For additional information, please
see the Company's website www.chinabiologic.com.
China Biologic Products, Inc.
Mr. Ming Yin
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
SOURCE China Biologic Products, Inc.
Press spacebar to pause and continue. Press esc to stop.